MCID: SPR012
MIFTS: 34

Separation Anxiety Disorder malady

Category: Mental diseases

Aliases & Classifications for Separation Anxiety Disorder

About this section

Aliases & Descriptions for Separation Anxiety Disorder:

Name: Separation Anxiety Disorder 10 12 65
 
Separation Anxiety Disorder of Childhood 65

Classifications:



External Ids:

Disease Ontology10 DOID:10685
ICD1027 F93.0
UMLS65 C0003477, C1527281

Summaries for Separation Anxiety Disorder

About this section
Disease Ontology:10 An anxiety disorder that involves the feeling of excessive and inappropriate levels of anxiety over being separated from a person to whom the individual has a strong emotional attachment or place.

MalaCards based summary: Separation Anxiety Disorder, also known as separation anxiety disorder of childhood, is related to retinitis and ring chromosome 14 syndrome. An important gene associated with Separation Anxiety Disorder is DRD4 (Dopamine Receptor D4), and among its related pathways are Monoamine GPCRs and GPCRs, Other. Affiliated tissues include brain, bone and lung.

Wikipedia:68 Separation anxiety disorder (SAD), is a psychological condition in which an individual experiences... more...

Related Diseases for Separation Anxiety Disorder

About this section

Diseases related to Separation Anxiety Disorder via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 139)
idRelated DiseaseScoreTop Affiliating Genes
1retinitis30.6HLA-A, HLA-B
2ring chromosome 14 syndrome10.5HTR2A, NBAS
3kluver-bucy syndrome10.5HTR2A, SLC6A3
4paranoid personality disorder10.5DRD4, HTR2A
5prostate adenocarcinoma10.5HTR2A, SLC6A3
6xerophthalmia10.4HTR2A, HTR7
7kleptomania10.4DRD4, HTR2A, SLC6A3
8liver leiomyoma10.4HTR2A, HTR7
9perrault syndrome10.4DRD4, HTR2A, SLC6A3
10chorioangioma10.4DRD4, HTR2A, SLC6A3
11uterine corpus adenomatoid tumor10.4HTR2A, SLC6A3
12hemolytic-uremic syndrome10.4HTR2A, TSPO
13chronic gonorrhea of cervix10.4DRD4, HTR2A, SLC6A3
14coronary thrombosis10.4HTR2A, HTR7
15breast cancer10.4
16steatorrhea10.4DRD4, HTR2A, HTR7
17breast osteosarcoma10.4DRD4, HLA-A, HTR2A
18periventricular leukomalacia10.4HLA-A, HLA-B
19postinfectious encephalomyelitis10.4HLA-A, HLA-B
20brachial plexus neoplasm10.4HTR2A, NBAS
21gastric pylorus carcinoma10.4HTR2A, HTR7, SLC6A3
22hydromyelia10.3HLA-A, HLA-B
23anthracosis10.3HLA-A, HLA-B
24exostosis10.3HLA-A, HTR2A
25undetermined early-onset epileptic encephalopathy10.3HLA-A, HLA-B
26intermediate uveitis10.3HLA-A, HLA-B
27c1 inhibitor deficiency10.3HTR2A, HTR7, TSPO
28anxiety disorder10.3
29prostate malignant phyllodes tumor10.3HLA-A, HLA-B
30tympanosclerosis10.3HTR2A, HTR7
31wernicke-korsakoff syndrome10.3HTR2A, HTR7, TSPO
32acquired thrombocytopenia10.3HLA-A, HLA-B
33subcorneal pustular dermatosis10.3HLA-A, HLA-B
34estrogen excess10.2HLA-A, HLA-B, HTR2A
35albinism, oculocutaneous, type v10.2DRD4, HTR2A, HTR7
36marasmus10.2HTR2A, HTR7
37gonococcal iridocyclitis10.2HLA-A, HLA-B
38opportunistic mycosis10.2DRD4, HLA-A, HTR2A, SLC6A3
39iridocyclitis10.2HLA-A, HLA-B, HLA-C
40psoriasis10.2HLA-A, HLA-B, HLA-C
41acneiform dermatitis10.2HLA-A, HLA-B, HLA-C
42lacrimal duct obstruction10.2HLA-A, HLA-B, HLA-C
43human herpesvirus 810.2HLA-A, HLA-B, HLA-C
44pulmonary nodular lymphoid hyperplasia10.2HLA-A, HLA-B, HLA-C
45inner ear disease10.2HTR2A, HTR7
46laryngeal adductor paralysis10.2DRD4, HTR2A, HTR7
47root resorption10.2HLA-A, HLA-B, HLA-C
48hemolytic anemia10.2HLA-A, HLA-B, HLA-C
49narcolepsy 210.2DRD4, HTR2A, HTR7, SLC6A3
50glycogen storage disease iiia10.2HLA-A, HLA-B, HLA-C

Graphical network of the top 20 diseases related to Separation Anxiety Disorder:



Diseases related to separation anxiety disorder

Symptoms for Separation Anxiety Disorder

About this section

Drugs & Therapeutics for Separation Anxiety Disorder

About this section

Drugs for Separation Anxiety Disorder (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 87)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
SevofluraneapprovedPhase 442928523-86-65206
Synonyms:
1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane
28523-86-6
AC-15484
AC1L1JU0
BRN 2041023
Bax 3084
C009250
C07520
C4H3F7O
CHEBI:9130
CHEMBL1200694
CID5206
D00547
DB01236
F0691
Fluoromethyl 1,1,1,3,3,3-Hexafluoroisopropyl Ether
Fluoromethyl 2,2,2-trifluoro-1-(trifluoromethyl)ethyl ether
I14-13357
LS-67851
MR6S4
 
MR_6S4
MolPort-001-775-746
NCGC00167421-01
PC4681
Sevofluran
Sevoflurane
Sevoflurane (JAN/USAN/INN)
Sevoflurane [USAN:INN:BAN:JAN]
Sevoflurano
Sevoflurano [INN-Spanish]
Sevofluranum
Sevofluranum [INN-Latin]
Sevofrane
Sevorane
Sojourn
UNII-38LVP0K73A
Ultane
Ultane (TN)
ZINC01530810
fluoromethyl hexafluoroisopropyl ether
fluoromethyl-2,2,2-trifluoro-1-(trifluoromethyl)ethyl ether
sevoflurane
2
DexmedetomidineapprovedPhase 4470113775-47-668602, 5311068, 56032
Synonyms:
(+)-4-((S)-alpha,2,3-Trimethylbenzyl)imidazole
(+)-4-((S)-alpha,2,3-trimethylbenzyl)imidazole
(+)-medetomidine
(S)-medetomidine
113775-47-6
4-[(1S)-1-(2,3-Dimethylphenyl)ethyl]-1H-imidazole
4-[(1S)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole
5-[(1S)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole
AC1NSJXT
C07450
CHEBI:4466
CHEMBL778
CID5311068
D00514
DEXMEDETOMIDINE
Dexdor (T)
 
Dexmedetomidin
Dexmedetomidina
Dexmedetomidine
Dexmedetomidine (USAN/INN)
Dexmedetomidine Hydrochloride
Dexmedetomidinum
Dexmédétomidine
MPV 1440
MPV-1440
Medetomidina [Spanish]
Medetomidine
Medetomidinum [Latin]
NCGC00025347-01
PRECEDEX
Precedex
Precedex (TN)
Tocris-2023
ZINC04632106
3
LidocaineapprovedPhase 41103137-58-63676
Synonyms:
.alpha.-(Diethylamino)-2,6-acetoxylidide
.alpha.-Diethylamino-2,6-dimethylacetanilide
.alpha.-Diethylaminoaceto-2,6-xylidide
.omega.-Diethylamino-2,6-dimethylacetanilide
137-58-6
2-(Diethylamino)-2',6'-acetoxylidide
2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide
2-Diethylamino-N-(2,6-dimethyl-phenyl)-acetamide
2-Diethylamino-N-(2,6-dimethylphenyl)acetamide
4-12-00-02538 (Beilstein Handbook Reference)
6108-05-0 (MONOHYDROCHLORIDE MONOHYDRATE))
6108-05-0 (mono-hydrochloride, mono-hydrate)
73-78-9 (mono-hydrochloride)
AB00053581
AC-10282
AC1L1GGQ
AC1Q2Z7J
AKOS001026768
ARONIS23855
After Burn Double Strength Gel
After Burn Double Strength Spray
After Burn Gel
After Burn Spray
Afterburn
Akten
Alphacaine
Anestacon
Anestacon Jelly
BIDD:GT0342
BPBio1_000197
BRD-K52662033-001-02-6
BRD-K52662033-003-05-5
BRN 2215784
BSPBio_000179
BSPBio_001359
BSPBio_003004
Bikini Zone Medicated
Bikini Zone Medicated Creme
Bio-0767
Bio-scriptives Lidum
Bio-scriptives Lidum Hemorroidal (anorectal)
Bio-scriptives Lidum Topical Analgesic
Bio1_000379
Bio1_000868
Bio1_001357
Bio2_000079
Bio2_000559
Burn Relief Leader
C07073
C14H22N2O
CAS-73-78-9
CDS1_000283
CHEBI:6456
CHEMBL79
CID3676
CPD000058189
Cappicaine
Cito optadren
Comfortcaine
Cuivasil
Curacaine Transdermal Corporation
D00358
DB00281
Dalcaine
Dentipatch
Dentipatch (TN)
Derma Numb
DermaFlex
Desert Harvest Releveum
Diethylaminoaceto-2,6-xylidide
Dilocaine
DivK1c_000174
DivK1c_001323
Dr. Numb
Dr. Richs Numbing
Duncaine
EINECS 205-302-8
ELA-Max
EMBOLEX
Emla
Emla Cream
Esracaine
FT-0082378
Gigi Anesthetic Numbing
Gravocain
H-releve Hemorrhoidal
HMS1791D21
HMS1989D21
HMS2051C21
HMS2089E15
HMS548M19
HSDB 3350
Hawaiian Tropic
Hush Anesthetic
I01-2704
IDI1_000174
IDI1_033829
Isicaina
Isicaine
Jetocaine
KBio1_000174
KBio2_000079
KBio2_001598
KBio2_002647
KBio2_004166
KBio2_005215
KBio2_006734
KBio3_000157
KBio3_000158
KBio3_002224
KBioGR_000079
KBioGR_000599
KBioSS_000079
KBioSS_001598
L-Caine
L0156
L1026_SIGMA
L7757_SIGMA
LIDOCAINE (73-58-6 (MONOHYDROCHLORIDE)
LIDOPEN
LQZ
LS-805
Lanabiotic
 
Laryng-o-jet
Leostesin
Lida-Mantle
Lidall
Lidocaina
Lidocaina [INN-Spanish]
Lidocaine
Lidocaine (JP15/USP/INN)
Lidocaine (VAN)
Lidocaine 4% Cream
Lidocaine Carbonate
Lidocaine Hydrocarbonate
Lidocaine Hydrochloride
Lidocaine Monohydrochloride
Lidocaine [USAN:INN:JAN]
Lidocaine hydrochloride
Lidocainum
Lidocainum [INN-Latin]
Lidocare Mist
Lidocaton
Lidocream 4
Lidocream 5
Lidoderm
Lidoderm 5
Lidoject-1
Lidoject-2
Lifestyles Epic Male Genital Desensitizer
Lignocaine
Lignocainum
Lingocaine
Lmx4
Lmx5
Lopac-L-5647
Lopac0_000669
MLS000069724
MLS000758263
MLS001074177
Maricaine
Maybridge1_002571
MolPort-001-783-478
N-(2,6-dimethylphenyl)-N(2),N(2)-diethylglycinamide
N-(2,6-dimethylphenyl)-N~2~,N~2~-diethylglycinamide
NCGC00015611-01
NCGC00015611-02
NCGC00015611-03
NCGC00015611-04
NCGC00015611-14
NCGC00022176-05
NCGC00022176-06
NCGC00022176-07
NCGC00022176-08
NCGC00022176-09
NINDS_000174
NSC 40030
NSC40030
Norwood Sunburn Spray
Numb Master Topical Anesthetic
Numb Nuts
Ocean Potion Instant Burn Relief Ice
Octocaine
Octocaine-100
Octocaine-50
Plum Smooth Plumb Numb Gelee
Premjact Male Desensitizer Pound International
Prestwick0_000050
Prestwick1_000050
Prestwick2_000050
Prestwick3_000050
Recticare
Remicaine
Rocephin Kit
Rucaina
S1357_Selleck
SAM001247018
SMR000058189
SPBio_001525
SPBio_002100
STK552033
Simplicity Desensitizing
Simply Numb Endure
Solarcaine
Solarcaine aloe extra burn relief cream
Solcain
Sole Serum
Spectrum2_001343
Spectrum3_001392
Spectrum4_000070
Spectrum5_001549
Spectrum_001118
UNII-98PI200987
WLN: 2N2 & 1VMR B1 F1
Walgreens Aloe Vera Pain Relieving
Xilina
Xilocaina
Xilocaina [Italian]
Xllina
Xycaine
Xylestesin
Xylesthesin
Xylocain
Xylocaine
Xylocaine (TN)
Xylocaine 5% Spinal
Xylocaine CO2
Xylocaine Dental Ointment
Xylocaine Endotracheal
Xylocaine Test Dose
Xylocaine Viscous
Xylocaine-Mpf
Xylocaine-Mpf with Glucose
Xylocaine-mpf
Xylocard
Xylocitin
Xyloneural (free base)
Xylotox
Zcaine Fast Acting Anesthetic
Zilactin-L
Zingo
alfa-Dietilamino-2,6-dimetilacetanilide
alfa-Dietilamino-2,6-dimetilacetanilide [Italian]
alpha-Diethylamino-2,6-dimethylacetanilide
alpha-diethylamino-2,6-dimethylacetanilide
lidocaine
nchembio.65-comp16
α-diethylamino-2,6-dimethylacetanilide
4
Alfentanilapproved, illicitPhase 43571195-58-951263
Synonyms:
5-26-13-00110 (Beilstein Handbook Reference)
70879-28-6 (hydrochloride)
71195-58-9
AC1L1ARM
AC1Q6F0S
ALFENTANIL
Alfenta
Alfentanil
Alfentanil (INN)
Alfentanil [INN:BAN]
Alfentanilum
Alfentanilum [INN-Latin]
Alfentanyl
BRN 1188293
C08005
CHEBI:127190
CHEBI:2569
 
CHEMBL634
CID51263
D07122
DB00802
DEA No. 9737
HSDB 6789
L001231
LS-119259
MolPort-004-285-887
N-(1-(2-(4-Ethyl-4,5-dihydro-5-oxotetrazolyl)ethyl)-4-(methoxymethyl)-4-piperidyl)-N-phenylpropionamid
N-(1-(2-(4-Ethyl-4,5-dihydro-5-oxotetrazolyl)ethyl)-4-(methoxymethyl)-4-piperidyl)propionanilid
N-(1-(2-(4-Ethyl-5-oxo-2-tetrazolin-1-yl)ethyl)-4-(methoxymethyl)-4-piperidyl)propionanilide
N-[1-[2-(4-Ethyl-5-oxo-2-tetrazolin-1-yl)ethyl]-4-(methoxymethyl)-4-piperidyl]propionanilide
N-[1-[2-(4-ethyl-5-oxotetrazol-1-yl)ethyl]-4-(methoxymethyl)piperidin-4-yl]-N-phenylpropanamide
N-{1-[2-(4-ethyl-5-oxo-4,5-dihydro-1H-tetrazol-1-yl)ethyl]-4-(methoxymethyl)piperidin-4-yl}-N-phenylpropanamide
N-{1-[2-(4-ethyl-5-oxo-4,5-dihydro-1H-tetrazol-1-yl)ethyl]-4-[(methyloxy)methyl]piperidin-4-yl}-N-phenylpropanamide
Rapifen (TN)
UNII-1N74HM2BS7
5
EpinephrineapprovedPhase 483451-43-45816
Synonyms:
(-)-(R)-Epinephrine
(-)-3,4-Dihydroxy-a-[2-(methylamino)ethyl]benzyl alcohol
(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol
(-)-3,4-Dihydroxy-alpha-[2-(methylamino)ethyl]benzyl alcohol
(-)-3,4-dihydroxy-a-[(methylamino)methyl]-Benzyl alcohol
(-)-3,4-dihydroxy-alpha-[(methylamino)methyl]-Benzyl alcohol
(-)-Adrenalin
(-)-Adrenaline
(-)-Epinephrine
(-)-R-Epinephrine
(R)-(-)-Adnephrine
(R)-(-)-Adrenaline
(R)-(-)-Epinephrine
(R)-(-)-Epirenamine
(R)-(−)-adrenaline
(R)-4-[1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol
(R)-4-[1-hydroxy-2-(methylamino)ethyl]-1,2-Benzenediol
(R)-Adrenaline
(R)-Epinephrine
(−)-adrenaline
02252_FLUKA
1-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol
1-Adrenalin
1-Epinephrine
4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol
4-(1-hydroxy-2-methylamino-ethyl)benzene-1,2-diol
4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-Benzenediol
4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol
4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
51-43-4
51-43-4 (FREE BASE)
51028-73-0
A0173
AC-13188
AC1L1L7B
ADR ADRENALINE
ADROP
AI3-19015
Adnephrine
Adrenaclick
Adrenal
Adrenalin
Adrenalin (TN)
Adrenalin in Oil
Adrenalin-Medihaler
Adrenalina
Adrenalina [DCIT]
Adrenaline
Adrenaline (JP15)
Adrenaline/Epinephrine
Adrenalinum
Adrenamine
Adrenan
Adrenapax
Adrenasol
Adrenatrate
Adrenine
Adrenodis
Adrenohorma
Adrenosan
Adrenutol
Adrin
Adrine
Ana-Guard
Ana-Kit
Antiasthmatique
Asmatane Mist
Asthma meter mist
Asthma-nefrin
Asthmahaler Mist
Asthmanefrin
Astmahalin
Astminhal
Auvi-q
BIDD:GT0119
Balmadren
Bernarenin
Biorenine
Bosmin
Brevirenin
Bronkaid
Bronkaid Mist
Bronkaid Suspension Mist
Bupivacaine Hcl and Epinephrine
C00788
CCRIS 4812
CHEBI:28918
CHEMBL679
CID5816
Chelafrin
Citanest Forte
Corisol
D-Epifrin
D-Epinephrine
D00095
DB00668
Drenamist
Dylephrin
Dyspne-Inhal
E4250_SIGMA
EINECS 200-098-7
EPI E Z PEN JR
EPIPEN E Z PEN
EPIPEN JR
Epi EZ Pen Jr
Epifrin
Epiglaufrin
Epinefrin
Epinefrin [Czech]
Epinefrina
Epinefrina [INN-Spanish]
Epinephran
Epinephrin
Epinephrine
Epinephrine (USP)
Epinephrine (USP/INN)
Epinephrine [USAN:INN:JAN]
Epinephrine bitartrate
Epinephrine chloride
Epinephrine hydrochloride
Epinephrinum
Epinephrinum [INN-Latin]
Epipen
Epipen (TN)
Epipen Auto-Injector
Epipen EZ Pen
Epipen Jr
Epipen Jr.
Epipen Jr. Auto-Injector
Epipen jr
Epirenamine
Epirenan
Epirenin
Epitrate
Eppy
 
Esphygmogenina
Exadrin
Glaucon
Glaucosan
Glauposine
Glycirenan
HSCI1_000215
HSDB 4289
Haemostasin
Haemostatin
Hektalin
Hemisine
Hemostasin
Hemostatin
Hypernephrin
Hyporenin
IOP
Intranefrin
Iontocaine
Isoptoepinal
Kidoline
L-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol
L-Adrenaline
L-Adrenaline Base
L-Epinehphrine
L-Epinephrine
L-Epirenamine
L-Methylaminoethanolcatechol
L-epinephrine
LS-156
Levo-Methylaminoethanolcatechol
Levoadrenaline
Levoepinephrine
Levorenen
Levorenin
Levorenine
Levoreninum
Lopac-E-4642
Lyodrin
Lyophrin
Medihaler-Epi
Metanephrin
Methylaminoethanolcatechol
Methylarterenol
Micronefrin
Micronephrine
MolPort-002-051-368
Mucidrina
Myosthenine
Mytrate
NCGC00015417-01
NCGC00142615-01
NCGC00142615-03
NCGC00142615-04
NCGC00142615-05
NCGC00142615-06
NCGC00142615-07
NSC 62786
NSC62786
Nephridine
Nieraline
PDSP1_001120
PDSP2_001104
Paranephrin
Primatene
Primatene Mist
Primatene Mist Refill
Prime Asthma Relief
R-(-)-Epinephrine
R-Adrenaline
RCRA waste no. P042
Racemic Epinephrine
Racepinephrine
Rcra waste number P042
Renagladin
Renaglandin
Renaglandulin
Renaleptine
Renalina
Renoform
Renostypricin
Renostypticin
Renostyptin
SMP1_000227
ST069368
SUS-PHRINE SULFITE-FREE
Scurenaline
Septocaine
Simplene
Sindrenina
Soladren
Sphygmogenin
Stryptirenal
Styptirenal
Supracapsulin
Supradin
Supranefran
Supranephrane
Supranephrine
Supranol
Suprarenaline
Suprarenin
Suprel
Surenine
Surrenine
Sus-Phrine
Sus-phrine
Susphrine
Sympathin I
Takamina
Takamine
Tokamina
Tonogen
Twinject
Twinject 0.15
Twinject 0.3
Twinject 0.30
UNII-YKH834O4BH
Vaponefrin
Vasoconstrictine
Vasoconstrictor
Vasodrine
Vasoton
Vasotonin
adrenaline
bmse000316
d-Adrenaline
epinephrine
l-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol
l-Adrenalin
l-Adrenaline
l-Epinephine
l-Epinephrine (synthetic)
l-Epirenamine
l-Methylaminoethanolcatechol
levoepinephrine
nchembio747-comp9
6
SertralineapprovedPhase 4, Phase 328279617-96-268617
Synonyms:
(+)-Sertraline
(1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine
(1S,4S)-Sertraline
(1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine
(1S-cis)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine
79559-97-0 (Hydrochloride)
79617-96-2
AB00514002
AB1004870
AC-15639
AC1L2A41
AC1Q3O5N
AC1Q3XJU
Apo-Sertraline
BIDD:GT0768
BIDD:PXR0193
BPBio1_001285
BRD-K82036761-003-02-1
BRN 5753709
BSPBio_001167
BSPBio_002698
C07246
C17H17Cl2N
CHEBI:9123
CHEMBL809
CID68617
CP 51974
Cp 51974
D02360
DB01104
DB08567
FT-0081122
HSDB 7037
KBio3_001918
 
KBioGR_001724
LS-94179
Lustral
MLS001195647
MLS002222308
MolPort-002-885-860
NCGC00092386-03
NCGC00092386-04
NCGC00092386-05
NCGC00092386-06
NCGC00092386-07
NCGC00092386-08
NCGC00092386-09
Prestwick3_001014
SMR000596516
SPBio_000385
SRE
Sertralina
Sertralina [Spanish]
Sertraline
Sertraline (INN)
Sertraline Hydrochloride
Sertraline [INN:BAN]
Sertraline [Zoloft]
Sertraline hydrochloride
Sertralinum
Sertralinum [Latin]
Spectrum2_000493
Spectrum3_001079
Spectrum4_001232
Sultamicillin Tosylate
UNII-QUC7NX6WMB
Zoloft
cis-(+)-Sertraline
sertraline
sertraline (Zoloft)
7
Midazolamapproved, illicitPhase 4, Phase 3, Phase 263559467-70-84192
Synonyms:
4H-Imidazo[1,5-a][1,4]benzodiazepine, 8-chloro-6-(2-fluoro-phenyl)-1-methyl-, (Z)-2-butenedioate
59467-70-8
8-Chlor-6-(2-fluorphenyl)-1-methyl-4H-imidazo(1,5-a)(1,4)benzodiazepin
8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine
8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5a][1,4]benzodiazepine hydrochloride
8-Chloro-6-(O-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]-benzodiazepine
8-Chloro-6-(o-fluorophenyl)-1-methyl-4H-imidazo(1,5-a)(1,4)benzodiazepine
AC-18749
AC1L1HMA
BIDD:GT0647
BRN 0625572
Buccolam
C07524
C18H13ClFN3
CHEMBL655
CID4192
D00550
DB00683
DEA No. 2884
Dazolam
Dea No. 2884
Dormicum
 
Dormicum (TN)
EINECS 261-774-5
LS-77780
Midanium
Midazolam
Midazolam (JAN/INN)
Midazolam Base
Midazolam Hcl
Midazolam Hydrochloride
Midazolam [INN:BAN:JAN]
Midazolamum
Midazolamum [INN-Latin]
Midosed
MolPort-003-849-219
NCGC00168254-01
Ro 21-3981
TL8003787
UC429_SIGMA
UNII-R60L0SM5BC
Versed
ZINC00001732
midazolam
nchembio747-comp32
8
Gabapentinapproved, investigationalPhase 426960142-96-33446
Synonyms:
1-(Aminomethyl)-cyclohexaneacetic acid
1-(Aminomethyl)cyclohexaneacetic acid
2-[1-(aminomethyl)cyclohexyl]acetic acid
60142-96-3
AC-1485
AC1L1FYE
AC1Q53PH
AKOS000280865
Aclonium
Apo-Gabapentin
Apotex brand of gabapentin
Aventis brand of gabapentin
BB_SC-1512
BIDD:GT0656
BPBio1_000993
BRN 2359739
BSPBio_000901
C040029
C9H17NO2
CAS-60142-96-3
CCRIS 7210
CHEBI:188316
CHEBI:42797
CHEMBL940
CI 945
CI-945
CID3446
D00332
DB00996
DDS-2003
DM-1796
DM-5689
EINECS 262-076-3
EU-0100582
G-154
G0318
G154_SIGMA
GBN
GOE 2450
Gabapen
Gabapentin
Gabapentin (JAN/USAN/INN)
Gabapentin GR
Gabapentin Hexal
Gabapentin Kit
Gabapentin Stada
Gabapentin [USAN:INN:BAN]
Gabapentin-ratiopharm
Gabapentina
Gabapentine
Gabapentine [INN-French]
Gabapentino
Gabapentino [INN-Spanish]
Gabapentino [Spanish]
Gabapentinum
 
Gabapentinum [INN-Latin]
Gabapetin
Go 3450
Goe-3450
Gralise
Gralise Starter Pack
HMS1570N03
HMS2089J03
HSDB 7364
Hexal brand of gabapentin
I06-0677
L000733
LS-7194
Lopac-G-154
Lopac0_000582
MLS000069358
MolPort-000-883-862
NCGC00015466-01
NCGC00015466-02
NCGC00015466-06
NCGC00015466-09
NCGC00016891-01
NCGC00021545-02
NCGC00021545-04
NCGC00021545-05
NSC742194
Neurontin
Neurontin (TN)
Novo-Gabapentin
Novo-Gabapentine
Novopharm brand of gabapentin
PMS-Gabapentin
Parke Davis brand of gabapentin
Pfizer brand of gabapentin
Pharmascience brand of gabapentin
Prestwick0_000861
Prestwick1_000861
Prestwick2_000861
Prestwick3_000861
Prestwick_151
S2133_Selleck
SMR000058311
SPBio_002822
STK598009
Serada
Stadapharm brand of gabapentin
TL8003814
Tocris-0806
UNII-6CW7F3G59X
Vultin
Warner-Lambert brand of gabapentin
[1-(AMINOMETHYL)CYCLOHEXYL]ACETIC ACID
gabapentin
gabapentin (Neurontin)
gabapentina
gabapentinium
ratiopharm brand of gabapentin
9
KetamineapprovedPhase 44676740-88-13821
Synonyms:
(+-)-Ketamine
(+/-)-2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone
(+/-)-2-(o-Chlorophenyl)-2-(methylamino)cyclohexanone
(+/-)-Ketamine
(-)-Ketamine
(S)-(-)-Ketamine
(S)-Ketamine
(±)-ketamine
100477-72-3
2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone
2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone
2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one
2-(Methylamino)-2-(2-chlorophenyl)cyclohexanone
2-(methylamino)-2-(2-chlorophenyl)cyclohexanone
2-(o-Chlorophenyl)-2-(methylamino)-cyclohexanone
2-(o-Chlorophenyl)-2-(methylamino)cyclohexanone
2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone
33643-45-7
6740-88-1
79499-51-7
AC1L1GSH
AC1Q40UR
AKOS001053247
BRN 2216965
C07525
C13H16ClNO
CHEBI:138833
CHEBI:6121
CHEMBL742
CI 581 base
CI-581
CID3821
CLSTA 20
Calypsol
Cetamina
Cetamina [INN-Spanish]
Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)- (9CI)
Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)-, (+-)- (9CI)
Cyclohexanone, 2-(o-chlorophenyl)-2-(methylamino)-, (+/-)- (8CI)
D08098
DB01221
DEA No. 7285
DL-ketamine
 
DivK1c_000217
EINECS 229-804-1
Esketamine
Green
IDI1_000217
KBio1_000217
KETAMINE
KETAMINE HCL
Ketaject
Ketalar
Ketalar base
Ketamina
Ketamine (INN)
Ketamine Base
Ketamine HCL
Ketamine Hydrochloride
Ketamine [INN:BAN]
Ketamine hydrochloride
Ketaminum
Ketaminum [INN-Latin]
Ketanest
Ketoject
Ketolar
L-Ketamine
LS-57301
MLS001331674
MolPort-001-838-070
NCGC00159480-02
NCGC00159480-03
NINDS_000217
NMDA
NSC 70151
NSC70151
SMR000238141
Special K
Special K [street name]
Special k
T385
Tekam
Tekam (TN)
UNII-690G0D6V8H
dl-Ketamine
ketamine
l-Ketamine
10
CitalopramapprovedPhase 4, Phase 149459729-33-82771
Synonyms:
1,3-Dihydro-1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-5-isobenzofurancarbonitrile
1,3-dihydro[3,4]benzofuran-5-carbonitrile
1-(3-(Dimethylamino)propyl)-1-(p-fluorophenyl)-5-phthalancarbonitrile
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile
59729-33-8
AB00513896
AC-12214
AC1L1EFH
AE-641/00603021
Akarin
BPBio1_000929
BRD-A47598013-004-02-0
BSPBio_000843
Bonitrile
C07572
C20H21FN2O
CHEBI:3723
CHEMBL549
CID2771
CPD000465669
Celapram
Celexa
Celius
Ciazil
Cilift
Cipram
Cipramil
Ciprapine
Citabax
Citadur
Citadur (TN)
Citalec
Citalopram
Citalopram (USP/INN)
Citalopram Hydrobromide
Citalopram [Celexa]
Citalopram [INN:BAN]
Citalopram hydrobromide
Citalopramum
Citalopramum [INN-Latin]
 
Citol
Citopam
Citox
Citrol
Cytalopram
D07704
DB00215
Dalsan
EINECS 261-891-1
Elopram
HMS2090O09
HMS2093A14
Humorup
I01-0382
InChI=1/C20H21FN2O/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20/h4-9,12H,3,10-11,14H2,1-2H3
L001223
LS-84327
Lopac0_000258
Lu 10-171
Lu-10-171
MolPort-003-666-794
NCGC00015267-07
NCGC00025160-02
Nitalapram
Oropram
Perrigo Citalopram
Pramcit
Prestwick3_000692
Recital
SAM002589960
ST069372
STL058639
Seropram
Talam
Talohexal
Temperax
UNII-0DHU5B8D6V
Vodelax
Zentius
Zetalo
[3H]Citalopram
citalopram
11RacepinephrinePhase 4834
12Sodium Channel BlockersPhase 41180
13Epinephryl boratePhase 4834
14Anti-Arrhythmia AgentsPhase 42371
15Diuretics, Potassium SparingPhase 41445
16Anesthetics, LocalPhase 42347
17Anesthetics, InhalationPhase 4511
18Antiparkinson AgentsPhase 4, Phase 11312
19calcium channel blockersPhase 41743
20Calcium, DietaryPhase 44678
21Antidepressive Agents, Second-GenerationPhase 4, Phase 3, Phase 11087
22Antimanic AgentsPhase 4663
23Antidepressive AgentsPhase 4, Phase 3, Phase 12367
24Tranquilizing AgentsPhase 4, Phase 3, Phase 23597
25NarcoticsPhase 42709
26Platelet Aggregation InhibitorsPhase 41935
27Analgesics, OpioidPhase 42304
28AnticonvulsantsPhase 42249
29Serotonin Uptake InhibitorsPhase 4, Phase 3, Phase 11369
30Adrenergic AgonistsPhase 4, Phase 22331
31Adrenergic alpha-2 Receptor AgonistsPhase 4, Phase 2790
32Adrenergic alpha-AgonistsPhase 4, Phase 21300
33Serotonin AgentsPhase 4, Phase 3, Phase 12668
34
SerotoninPhase 4, Phase 3, Phase 1314750-67-95202
Synonyms:
3-(2-Aminoethyl)-1H-indol-5-ol
3-(2-Aminoethyl)indol-5-ol
3-(b-Aminoethyl)-5-hydroxyindole
5-HT
5-HTA
5-Hydroxy-3-(b-aminoethyl)indole
 
5-Hydroxy-tryptamine
5-Hydroxyltryptamine
5-Hydroxytriptamine
5-Hydroxytryptamine
Antemovis
DS substance
Enteramin
Enteramine
35Peripheral Nervous System AgentsPhase 4, Phase 118510
36Neurotransmitter AgentsPhase 4, Phase 3, Phase 2, Phase 114795
37Neurotransmitter Uptake InhibitorsPhase 4, Phase 3, Phase 2, Phase 12857
38Psychotropic DrugsPhase 4, Phase 3, Phase 2, Phase 15501
39AnalgesicsPhase 49358
40Adrenergic AgentsPhase 4, Phase 24204
41Central Nervous System DepressantsPhase 4, Phase 3, Phase 210016
42Excitatory Amino Acid AntagonistsPhase 41095
43Analgesics, Non-NarcoticPhase 45184
44Excitatory Amino AcidsPhase 41109
45GABA ModulatorsPhase 4, Phase 3, Phase 2657
46Anti-Anxiety AgentsPhase 4, Phase 3, Phase 21529
47Anesthetics, DissociativePhase 4417
48AnestheticsPhase 4, Phase 3, Phase 27385
49Anesthetics, IntravenousPhase 4, Phase 3, Phase 21943
50Anesthetics, GeneralPhase 4, Phase 3, Phase 22274

Interventional clinical trials:

(show top 50)    (show all 68)
idNameStatusNCT IDPhase
1Brain Markers of Anxiety Disorders and SSRI/CBT Treatment in Children and AdolescentsCompletedNCT01160588Phase 4
2Intranasal Dexmedetomidine vs Midazolam-ketamine Combination for Premedication of Pediatric PatientsCompletedNCT02072083Phase 4
3The Effect of Parental Presence on Dental FearCompletedNCT02619981Phase 4
4Sevoflurane Induced Emergence AgitationCompletedNCT02022488Phase 4
5Plasma Gabapentin Concentration During and Following Cardiac BypassCompletedNCT01022736Phase 4
6Vilazodone for Separation Anxiety DisorderRecruitingNCT01999920Phase 4
7A Comparison of Two Doses of Intranasal Dexmedetomidine for Premedication in ChildrenRecruitingNCT02459509Phase 4
8Developing New Clinical Management StrategiesActive, not recruitingNCT02082392Phase 4
9Treatment for Anxiety in ChildrenCompletedNCT00000389Phase 3
10Computerized Cognitive Behavioral Therapy for Childhood Anxiety in Community Health CentersCompletedNCT01416805Phase 3
11Cognitive-Behavioral Treatment for Anxiety Disorders in Children With Autism Spectrum DisordersCompletedNCT01178385Phase 2, Phase 3
12A Study of Pediatric Patients With Attention Deficit/Hyperactivity DisorderCompletedNCT00922636Phase 2, Phase 3
13Reduction of Preoperative Anxiety in Children: Electronic Tab vs MidazolamCompletedNCT02192710Phase 3
14Study to See if Microcoil Insertion Reduces the Rate of Open Thoracotomy for Removal of Lung NodulesCompletedNCT01028417Phase 3
15Psychotherapy for Anxiety in Children With Autism Spectrum DisorderRecruitingNCT02028247Phase 3
16Psychotherapy for Anxiety in Children With Autism Spectrum DisorderRecruitingNCT02111395Phase 3
17A Comparison of Midazolam and Zolpidem as Oral Premedication in ChildrenRecruitingNCT02096900Phase 3
18Child and Adolescent Anxiety Disorders (CAMS)Active, not recruitingNCT00052078Phase 3
19Sedation in the Intensive Care UnitActive, not recruitingNCT00221520Phase 3
20SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)CompletedNCT01470469Phase 2
21Modular Cognitive Behavioral Therapy for the Treatment of Child Anxiety Disorders in Elementary School SettingsCompletedNCT00569829Phase 2
22Effectiveness Study of CBT for Anxiety in ChildrenCompletedNCT00586586Phase 2
23Effects of Parental Behavior on Child Anxiety RegulationCompletedNCT00593515Phase 2
24Effectiveness of Cognitive Behavioral Therapy (CBT) for Child Anxiety Disorders in Community Clinics in NorwayCompletedNCT00735995Phase 2
25A GameBoy as a Distraction Before Surgery in ChildrenCompletedNCT00176670Phase 2
26Treatment Study for Rural Latino Youth With AnxietyRecruitingNCT01491880Phase 1, Phase 2
27Brief Behavioral Treatment for Anxiety in Young ChildrenActive, not recruitingNCT02051192Phase 1, Phase 2
28A Research Study of How Teens With and Without an Anxiety Disorder Make DecisionsCompletedNCT00104195Phase 1
29G-CSF to Treat Crohn's DiseaseCompletedNCT00025805Phase 1
30Cipralex® for Anxiety Disorders in AdolescentsRecruitingNCT01293838Phase 1
31Youth Mayo Clinic Anxiety Coach Randomized Controlled TrialNot yet recruitingNCT02205203Phase 1
32TAFF-Psychological Treatment of Separation Anxiety DisorderCompletedNCT00255112
33Internet-delivered Treatment for Children With Anxiety Disorders in a Rural Area; an Open Trial in a Clinical SettingCompletedNCT02306356
34Cartoon Distraction and Parental Presence on Anxiety in Pediatric AnesthesiaCompletedNCT02027844
35Transdisciplinary Studies of CBT for Anxiety in Youth: Child Anxiety Treatment StudyCompletedNCT00774150
36Sleep, Mood, and Behavior StudyCompletedNCT00787397
37Treatment of Youth With ADHD and AnxietyCompletedNCT00012584
38Cognitive Behavioral Therapy for Anxiety Disorders in Adolescents With AutismCompletedNCT01563003
39CO2 Inhalation and Risk for Panic DisorderCompletedNCT00930657
40Internet-delivered Cognitive Behavior Therapy (CBT) for Children Age 8-12 Years With Anxiety DisordersCompletedNCT01533402
41Ventilatory Physiology in Children at Risk for AnxietyCompletedNCT00101777
42Reward-Related Processes and Brain FunctionCompletedNCT00029588
43Impact of the BB Box System on Postpartum Maternal Anxiety, Post Traumatic Stress and Mother-child RelationshipsCompletedNCT01566058
44Combination of Active or Placebo Attentional Bias Modification Treatment (ABMT) to Either Cognitive Behavioral Group Therapy (CBGT) or Psychoeducational Control Intervention (PCI) for Anxiety Disorders in ChildrenRecruitingNCT01687764
45Explanatory Clinical Trial of a Novel Parent Intervention for Childhood Anxiety (SPACE)RecruitingNCT02310152
46Building an Outcomes Assessment Infrastructure to Assess Anxiety TreatmentRecruitingNCT02305537
47Treatment of Pediatric Anxiety Disorders by Predicting Treatment Response Through Biocellular Markers and SleepRecruitingNCT02189213
48Acoustic Neuromodulation (ANM) for Youth With Anxiety DisordersRecruitingNCT02572973
49Attention Bias Modification Treatment for Anxious YouthRecruitingNCT01979263
50Comorbidity Between Balance and Childhood AnxietyRecruitingNCT00599742

Search NIH Clinical Center for Separation Anxiety Disorder

Genetic Tests for Separation Anxiety Disorder

About this section

Anatomical Context for Separation Anxiety Disorder

About this section

MalaCards organs/tissues related to Separation Anxiety Disorder:

33
Brain, Bone, Lung, Heart, Skeletal muscle, Breast, T cells

Animal Models for Separation Anxiety Disorder or affiliated genes

About this section

MGI Mouse Phenotypes related to Separation Anxiety Disorder:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes

Publications for Separation Anxiety Disorder

About this section

Articles related to Separation Anxiety Disorder:

(show top 50)    (show all 79)
idTitleAuthorsYear
1
Primary breast lymphoma presenting as non-healing axillary abscess. (26446318)
2015
2
Pyoderma gangrenosum in a patient with cutaneous T-cell lymphoma. (27051695)
2015
3
Comparison of PIRO, SOFA, and MEDS Scores for Predicting Mortality in Emergency Department Patients With Severe Sepsis and Septic Shock. (25377403)
2014
4
Modulation of tumor necrosis factor-stimulated gene-6 (TSG-6) expression in human endometrium. (24213015)
2014
5
Eosinophilic meningitis caused by Angiostrongylus cantonensis in an adolescent with mental retardation and pica disorder. (23445744)
2013
6
Molecular aberration studies in cases of idiopathic mental retardation: An update. (24019609)
2013
7
Evaluation of parasite subpopulations and genetic diversity of the msp1, msp2 and glurp genes during and following artesunate monotherapy treatment of Plasmodium falciparum malaria in Western Cambodia. (24206588)
2013
8
Association of an MHC class II haplotype with increased risk of polymyositis in Hungarian Vizsla dogs. (23457575)
2013
9
Management options for persistent postoperative acromegaly. (23040748)
2012
10
Mast cells are required for the development of renal fibrosis in the rodent unilateral ureteral obstruction model. (21957176)
2012
11
Serious complication of percutaneous angioplasty with stent implantation in so called "chronic cerebrospinal venous insufficiency" in multiple sclerosis patient. (23249660)
2012
12
Cyclin D1-negative blastoid mantle cell lymphoma identified by SOX11 expression. (22251940)
2012
13
Why is genetic screening for autosomal dominant disorders underused in families? The case of hereditary hemorrhagic telangiectasia. (21637104)
2011
14
Is it effective to raise the irradiation dose from 80 to 85 Gy in gamma knife radiosurgery for trigeminal neuralgia? (20431328)
2010
15
Chromosomal gains and losses indicate oncogene and tumor suppressor gene candidates in salivary gland tumors. (18190242)
2008
16
Carbimazole embryopathy-bilateral choanal atresia and patent vitello-intestinal duct: a case report and review of literature. (18671255)
2008
17
Substrate recognition reduces side-chain flexibility for conserved hydrophobic residues in human Pin1. (17355867)
2007
18
Fine needle aspiration cytology in mediastinal myxoid liposarcoma: a case report. (17536554)
2007
19
Genome of the Acidianus bottle-shaped virus and insights into the replication and packaging mechanisms. (17412384)
2007
20
Hemodialysis modulates gene expression profile in skeletal muscle. (16997058)
2006
21
Dilation of Virchow-Robin spaces in CADASIL. (16490051)
2006
22
Candida spondylodiscitis and epidural abscess: management with shorter courses of anti-fungal therapy in combination with surgical debridement. (15979485)
2005
23
Recent progress in relaxin-3-related research. (15956687)
2005
24
A model for the study of Helicobacter pylori interaction with human gastric acid secretion. (15064083)
2004
25
Hirsutism: common clinical problem or index of serious disease? (15775883)
2004
26
Inducible nitric oxide synthase (iNOS) in immune-mediated demyelination and Wallerian degeneration of the rat peripheral nervous system. (15144861)
2004
27
Circulating adhesion molecules are correlated with ultrasonic assessment of carotid plaques. (12570870)
2003
28
Tumour necrosis factor-alpha-induced expression of intercellular adhesion molecule-1 on human eosinophilic leukaemia EoL-1 cells is mediated by the activation of nuclear factor-kappaB pathway. (12580918)
2003
29
Frequent chromosome aberrations revealed by molecular cytogenetic studies in patients with aniridia. (12386836)
2002
30
Use of terminal transferase-dependent antisense RNA amplification to determine the transcription start site of the Snrpn gene in individual neurons. (10710442)
2000
31
Cooperation between transcription factor AP-1 and NF-kappaB in the induction of interleukin-8 in human pancreatic adenocarcinoma cells by hypoxia. (10638705)
1999
32
In-vivo delivery of therapeutic proteins by genetically-modified cells: comparison of organoids and human serum albumin alginate-coated beads. (10665341)
1999
33
Cocaine abuse and corticogenesis. (9464680)
1998
34
Epidermal growth factor (EGF) in tears in excimer laser photorefractive keratectomy. Responsible for postoperative refraction and "haze"?]. (9545784)
1998
35
Interleukin-10- and corticosteroid-induced reduction in type I procollagen in a human ex vivo scar culture. (9166103)
1997
36
The kringle domains of human plasminogen. (9524763)
1997
37
Expression of the PEA3 group of ETS-related transcription factors in human breast-cancer cells. (9052761)
1997
38
Comparison of calcitriol treatment with etidronate-calcitriol and calcitonin-calcitriol combinations in Turkish women with postmenopausal osteoporosis: a prospective study. (9192511)
1997
39
Early-onset periodontitis associated with Weary-Kindler syndrome: a case report. (8910840)
1996
40
Induction of neurite outgrowth by interleukin-6 is accompanied by activation of Stat3 signaling pathway in a variant PC12 cell (E2) line. (8662645)
1996
41
Mammalian splicing factor SF1 is encoded by variant cDNAs and binds to RNA. (8752089)
1996
42
The muscle-specific phosphoglycerate mutase gene is specifically expressed in testis during spermatogenesis. (7867621)
1995
43
Molecular cloning and characterization of a ras-related gene of ran/tc4/spi1 subfamily in Giardia lamblia. (8006038)
1994
44
Zinc interactions and conserved motifs of the cGMP-binding cGMP-specific phosphodiesterase suggest that it is a zinc hydrolase. (8077192)
1994
45
Renal autotransplantation in the loin pain-hematuria syndrome: a cautionary note. (1496973)
1992
46
The Secretory Granule Protein 7B2 is Secreted in Parallel with Proopiomelanocortin and its End-Products by the Mouse Corticotroph Tumour Cells AtT-20. (19215457)
1991
47
Localized scleroderma 'en coup de sabre' with external eye muscle involvement at the same line. (6713721)
1984
48
Bile acid metabolism in benign recurrent intrahepatic cholestasis. Comparative studies on the icteric and anicteric phases of a single case. (437403)
1979
49
Interaction of human cathepsin D with the inhibitor pepstatin. (938470)
1976
50
Asbestosis claim succeeds. (4193585)
1970

Variations for Separation Anxiety Disorder

About this section

Expression for genes affiliated with Separation Anxiety Disorder

About this section
Search GEO for disease gene expression data for Separation Anxiety Disorder.

Pathways for genes affiliated with Separation Anxiety Disorder

About this section

GO Terms for genes affiliated with Separation Anxiety Disorder

About this section

Cellular components related to Separation Anxiety Disorder according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1cell surfaceGO:00099869.5HLA-A, HLA-B, HLA-C

Biological processes related to Separation Anxiety Disorder according to GeneCards Suite gene sharing:

(show all 8)
idNameGO IDScoreTop Affiliating Genes
1protection from natural killer cell mediated cytotoxicityGO:004227010.2HLA-A, HLA-B
2positive regulation of T cell mediated cytotoxicityGO:000191610.1HLA-A, HLA-B
3behavioral response to cocaineGO:004814810.0DRD4, HTR2A
4smooth muscle contractionGO:00069399.8HTR2A, HTR7
5antigen processing and presentationGO:00198829.6HLA-A, HLA-B, HLA-C
6antigen processing and presentation of peptide antigen via MHC class IGO:00024749.5HLA-A, HLA-B, HLA-C
7positive regulation of penile erectionGO:00604069.5DRD4, OXT
8interferon-gamma-mediated signaling pathwayGO:00603339.2HLA-A, HLA-B, HLA-C

Molecular functions related to Separation Anxiety Disorder according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1peptide antigen bindingGO:00426059.8HLA-A, HLA-B

Sources for Separation Anxiety Disorder

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet